COVID-19 Virucides: Study By Singapore Researchers Show That Povidone-Iodine Demonstrates Rapid In -Vitro Virucidal Activity Against SARS-CoV-2
Source: COVID-19 Virucides Jul 11, 2020 5 years, 7 months, 4 days, 16 hours, 51 minutes ago
COVID-19 Virucides: Researchers from Duke-NUS Medical School In Singapore shows that Povidone-Iodine demonstrates rapid in vitro virucidal activity against sars-cov-2 coronavirus in a new study.
The research findings were published in the journal: Infectious Disease and Therapy Journal.
https://link.springer.com/article/10.1007/s40121-020-00316-3
Povidone-iodine (PVP-I), which is highly effective against a wide range of microorganisms, including bacteria, viruses and fungi and is typically used in hospitals and this is the first research to show its virucidal nature against the SARS-CoV-2 coronavirus.
Testing has demonstrated Povidone-Iodine’s strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds.
The researchers tested products made by Mundipharma under the Betadine brand that contain
Povidone-Iodine.
The products subjected to testing were: BETADINE
® antiseptic products, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I).
Raman Singh, CEO of Mundipharma told Thailand Medical News, "These results confirm our view that BETADINE
® antiseptic products, used appropriately and in conjunction with other preventative treatment options including PPE, can play a role in limiting the spread of infections, including COVID-19. It also provides the medical community as well as consumers with a science-based assurance that they are using a product that is a proven defense against COVID-19.”
The research conducted at Duke-NUS is complemented by Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia, that also demonstrated strong in-vitro virucidal activity, with the tested product BETADINE
® Gargle and Mouthwash (1.0% PVP-I) killing 99.99% of the SARS-CoV-2 virus in 15 seconds. The Malaysian TIDREC research has been accepted by the British Dental Journal (BDJ) and was published as a Letter on 26 June 2020. The journal is published by Springer Nature on behalf of the British Dental Association.
https://www.nature.com/articles/s41415-020-1794-1
BETADINE
® antiseptic products containing povidone iodine (PVP-I) have been proven effective in vitro against a wide range of viruses, including coronaviruses that have caused major outbreaks such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS).
For more about
COVID-19 Virucides, keep on logging to Thailand Medical News.
